Results 141 to 150 of about 3,743,885 (328)
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit+19 more
wiley +1 more source
Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson+11 more
wiley +1 more source
Real options analysis in the engineering company practice [PDF]
Václav Klepáč+2 more
openalex +1 more source
End of life decommissioning and recycling of solar panels in the United States. A real options analysis [PDF]
C. Echevarría Ruiz de Vargas+1 more
openalex +1 more source
When to wait for more evidence? Real options analysis in proton therapy. [PDF]
Grutters JP+7 more
europepmc +1 more source
None of the Above, Less of the Right: Parallel Patterns between Humans and LLMs on Multi-Choice Questions Answering [PDF]
Multiple-choice exam questions with "None of the above" (NA) options have been extensively studied in educational testing, in which existing research suggests that they better assess true knowledge. However, their impact on Large Language Models (LLMs) evaluation remains underexplored.
arxiv
Building Real Options into Physical Systems with Stochastic Mixed-Integer Programming [PDF]
The problem of building real options into physical systems has three features: real options are not as easily defined as financial options; path-dependency and interdependencies among projects mean that the standard tools of options analysis tools are ...
de Neufville, Richard, Wang, Tao
core
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu+11 more
wiley +1 more source
Evaluating a portfolio of projects through the real options analysis [PDF]
Aleksandr B. Lanchakov+2 more
openalex +1 more source